This is a preview of subscription content, log in via an institution to check access.
Reference
Institute for Clinical and Economic Review. Institute for Clinical and Economic Review Posts Draft Scoping Document on Treatments for Tardive Dyskinesia, including recently approved Ingrezza. Internet Document : 8 May 2017. Available from: URL: https://icer-review.org/announcements/td-draft-scope/
Rights and permissions
About this article
Cite this article
ICER posts scoping document on drugs for tardive dyskinesia. PharmacoEcon Outcomes News 778, 4 (2017). https://doi.org/10.1007/s40274-017-3981-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-017-3981-0